KKR Genetic Disorder L.P.

KKRS

KKR Genetic Disorder L.P. serves as an insider at KKR Group Finance Co. IX LLC 4.625% Subordinated Notes due 2061 (KKRS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$552.31M

Net Position

Net Seller

$552.31M

Companies Traded

KKRS, KKR

Active Period

Sep 2024 – May 2025

3 total trades

Most Recent

Sell KKRS

May 14, 2025 · $205.20M

KKR Genetic Disorder L.P.'s Insider Trading at KKR Group Finance Co. IX LLC 4.625% Subordinated Notes due 2061 (KKRS)

Buys

0 · $0.00

Sells

2 · $402.96M

Total Shares Bought

Total Shares Sold

12,000,000

KKRS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 14, 2025	Sell	6,000,000	$34.20	$205.20M	13,260,971
Mar 7, 2025	Sell	6,000,000	$32.96	$197.76M	19,260,972

KKR Genetic Disorder L.P.'s Insider Trading at KKR & Co. Inc. (KKR)

Buys

0 · $0.00

Sells

1 · $149.35M

Total Shares Bought

Total Shares Sold

5,800,000

KKR Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Sep 17, 2024	Sell	5,800,000	$25.75	$149.35M	25,260,972

Related Insiders

BARAKETT TIMOTHY R

Director

KKRBuy · Mar 5, 2026

BAE JOSEPH Y

director, officer: Co-Chief Executive Officer

KKRBuy · Mar 3, 2026

Mary N Dillon

director

KKRBuy · Mar 3, 2026

NUTTALL SCOTT C

director, officer: Co-Chief Executive Officer

KKRBuy · Mar 3, 2026

ROBERTS GEORGE R

Co-Executive Chairman

KKRSSell · Aug 7, 2025

Explore More Insider Trading Data

KKRS Insider Trading Activity

View all insider trades at KKR Group Finance Co. IX LLC 4.625% Subordinated Notes due 2061

Financial Services Sector Insider Trades

See insider activity across financial services stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity